Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Aptamer enters partnership with Microsaic Systems

(Sharecast News) - Aptamer Group announced a partnership with Microsaic Systems on Friday, to develop a panel of Optimer binders for integration into Microsaic's water testing system. The AIM-traded firm said the collaboration aimed to enhance continuous water monitoring by enabling rapid detection of multiple waterborne pathogens.

Microsaic recently acquired the Microtox water testing system.

Previous work with Aptamer's Covid-19 Optimer binders demonstrated successful integration into that system, showing superior detection performance compared to alternative affinity ligands like Affimers.

Those trials, conducted within the UK wastewater system, confirmed the efficacy of Optimer-enabled pathogen detectors.

Under the new agreement, Aptamer said it would develop Optimer binders for several major waterborne pathogens, including E.coli, cholera, cryptosporidium, legionella, and norovirus.

The binders would be integrated into Microsaic's pathogen detectors, providing rapid and sensitive detection of multiple pathogens crucial for public health.

Aptamer said the continuous water testing solution aimed to detect pathogens in real-time, eliminating delays associated with laboratory-based testing.

The system aimed for seamless integration with nationwide water systems, facilitating early detection of potential infections and enhancing public health safety.

"We are pleased to work with Microsaic and support their development of the water testing system," said chief technical officer Dr Arron Tolley

"Applying the pathogen detector within national water systems could help prevent disease outbreaks by rapidly identifying specific hotspots."

Dr Tolley said the robust nature of Optimer binders meant that they could work within tests as diverse as lab-based diagnostics and environmental water monitoring.

"Previous work has demonstrated that Optimer binders allow highly sensitive pathogen detection in the wastewater testing system, and we are pleased to build on this with the new team at Microsaic as they advance the platform to commerciality."

At 1347 BST, shares in Aptamer Group were up 5.43% at 0.74p.

Reporting by Josh White for

Share this article

Related Sharecast Articles

Chipmaker TSMC lifts sales guidance as AI boom continues
(Sharecast News) - Apple and Nvidia supplier TSMC lifted its sales guidance for the full year on Thursday as demand for its chips continues to be supported by the ongoing AI boom.
Craneware full-year revenue set to top expectations
(Sharecast News) - US healthcare management and support specialist Craneware reported a strong full-year sales performance in an update on Thursday, driven by ongoing investment in the Trisus platform and successful partner programmes, resulting in significant returns for its US healthcare provider customers.
Meta reportedly in talks to buy stake in Ray-Ban maker EssilorLuxottica
(Sharecast News) - Facebook parent company Meta is reportedly in discussions to buy a 5% stake in Italian-French eyewear maker EssilorLuxottica as the social-media giant looks to deepen its ties with the company that makes its Ray-Ban Meta smart glasses.
Midwich revenue rises, earnings fall in first half
(Sharecast News) - Specialist audio-visual distributor Midwich Group reported a robust first-half revenue performance on Thursday, but a fall in earnings amid challenging market conditions.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.